🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

FIVE at FIVE AU: ASX drives higher after Federal Budget; are meme stocks making a comeback?

Published 15/05/2024, 04:08 pm
© Reuters FIVE at FIVE AU: ASX drives higher after Federal Budget; are meme stocks making a comeback?
AXJO
-
BHP
-
RIO
-
ATOI
-
AXSO
-
AXKO
-
AXGD
-
AXMM
-
AXAT
-
AXSJ
-
AXHJ
-
AXFJ
-
TIOc1
-
SOUHY
-

The ASX is higher today on mining and health care gains.

Materials gained 1.35% and Healthcare was 1.01% higher. Energy was the drag, down 0.58%.

At time of writing, iron ore giants BHP (ASX:BHP) Group (up 2.5%) and Rio Tinto (ASX:RIO) (up 0.8%) alongside South32 (up 1.2%) drove the mining sector higher, contributing to a 1.3% sector rise.

Critical minerals and rare earths companies, including Pilbara Minerals (up 0.6%) and Lynas Rare Earths (up 1.4%), also saw gains following the Federal Government's announcement of $7 billion in tax incentives over 11 years from 2023-24 to support the sector.

Healthcare companies, such as Pro Medicus (up 3%) and hearing implant maker Cochlear (up 1.8%), strengthened, lifting the sector by 0.8%. Real estate investment trusts (up 0.9%) also performed well, with Stockland (up 2.2%), GPT GROUP (ASX:GPT) (up 2%) and Scentre (up 1.4%) making gains.

The S&P/ASX200 30.30 points or 0.39% to 7,757.10, crossing above its 50-day moving average. The index has lost 0.61% for the last five days but sits 1.94%below its 52-week high.

Top performing stocks in this index are Neuren Pharmaceuticals and IDP Education Ltd, up 5.35% and 5.29% respectively.

As for the small cap sector, the S&P/ASX Small Ordinaries (XSO) gained 0.016% today to 3,042.60 but is down 0.64% over the last five days.

General budget commentary

There have been mixed reactions to the Federal budget. They range from the harshest of criticism to the average person on the street happy to get anything from the government.

The Australian Shareholders Association gave its run down of the key points, which you can read here.

However, Lightyear Group CEO Michael Jeffriess expressed his concern in no uncertain terms.

"The 2024 Budget is a band-aid solution for a nation facing a financial storm," Jeffriess said. "We're talking about short-term fixes for problems that demand long-term vision and comprehensive planning. Who is going to pay for the four million Baby Boomers who will need aged care over the next 20 years?"

IG Markets analyst Tony Sycamore linked back to interest rates: “As the debate around the Federal Budget’s impact on inflation hots up, it's worth highlighting that the Australian Interest rate market is now pricing in a ~10% chance of a 25bp RBA rate cut at its Board meeting on December 10. while retaining a ~10% chance of a 25bp RBA rate hike by September.

“The key takeaway here is that the rates market appears comfortable that the Federal Budget struck the right balance between providing cost-of-living relief without inflaming inflationary concerns. There is a full 25bp rate cut priced in by next July.

“I expect further adjustments in pricing following this Thursday's labour force report and after the RBA meeting minutes are released next Tuesday.”

CreditorWatch chief economist Anneke Thompson said the budget threads the needle between cost-of-living relief and managing inflation.

“For all the measures announced in Tuesday night’s Federal Budget, the average Australian is likely to focus on one – the $300 energy bill rebate for each household. In conjunction with a boost to Rent Assistance, these are the key pillars of the Government’s attempts to help with ‘cost of living’ pressures.

"The Treasurer is attempting to ‘thread the needle’ here – helping Australians with their bills while not making the shorter-term fight against inflation harder. Of course, we won’t know if the Treasurer will be successful until early 2025, tellingly just before the Federal election which needs to be held by May.

"However, even if these measures do help to bring inflation down to within striking distance of the 2 to 3% target band by the end of 2024, the Reserve Bank of Australia (RBA) is unlikely to view this as enough to start cutting the cash rate. The RBA will look through these short-term impacts, much like they do with volatile items like fuel and fruit and vegetables."

CreditorWatch’s latest B2B Trade Payment Defaults data is at record highs and has been elevated for three straight months, after being on a slow rising trend over 2023. “The budget includes $325 energy bill relief for businesses on smaller electricity plans, as well as extending the $20,000 instant asset write-off scheme.

"These are small measures that will help businesses. But what businesses really need, especially the struggling food and beverage and construction sectors, is more confident consumers, as well home borrowers who can afford to engage builders to build houses.

“Unfortunately, this is unlikely to occur until the RBA begins to reduce the cash rate. Energy relief payments in the pockets of consumers, even in conjunction with already locked in tax cuts from July 2024, are unlikely to convince shoppers to go out and spend again. Inflation is still too far out of the target band, and the last thing the RBA wants is for goods inflation to take off again.

“The RBA will be watching services inflation closely, particularly in health and education, and the budget does little to ease pressures here. There are some savings in the NDIS, but these are offset by forecast additional spending in other areas. It will be a non-budget measure – reigning in population growth – that will have the biggest impact here. And the good news is, the forecasts for population are showing much lower growth over the next few years.

“The Federal Government has a great deal of control here, and has already made it clear that it is reducing student visa numbers dramatically. For mine, this is where the inflation fight will be won or lost, and it appears that we are finally now on the right path.”

Meme stock comeback

GameStop Corporation (NYSE: NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) experienced a significant rally reminiscent of the social-media-driven frenzy from three years ago.

GameStop's shares surged 60.1%, while AMC's stock increased by 32%. However, both stocks later relinquished a considerable portion of their earlier gains.

But it looks like meme stocks could be making a comeback.

GameStop client trading volumes jumped 3514% as the week began.

“The meme stock trading excitement we saw in 2021 reemerged this week, and some of our Australian traders took advantage of the price action. Webull saw trading volumes from Australian clients increase by over 3,500% in GameStop (GME) on Monday. Phenomena like this don’t tend to exist on the ASX, prompting local clients to seek volatility in other markets, where they can day-trade news events,” Webull Australia CEO Rob Talevski said.

“In this instance, it was an army of traders driving this stock in the US, triggering orders on after a cryptic image was posted online, which led to a 179% two-day jump in the stock by Tuesday's close.”

Five at five

GTI Energy welcomes US legislation banning the import of Russian uranium

GTI Energy Ltd (ASX:GTR, OTC:GTRIF) has welcomed the signing into law this week by US President Joe Biden of legislation banning the import of Russian-enriched uranium.

Read more

American Rare Earths stands to benefit from US tariff policy changes

American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) is well-placed to gain significantly from the recent US tariff policy changes targeting critical minerals and technology sectors.

Read more

Australian Gold and Copper hits new record high on “exceptional” Achilles results

Australian Gold and Copper Ltd (ASX:AGC) has hit a new record of $0.245 after delivering maximum grades of 45 g/t gold, +3,000 g/t silver and 38.8% lead+zinc in follow-up reverse circulation (RC) drilling at the Achilles discovery in the Cobar Basin of central New South Wales.

Read more

Recce Pharmaceuticals doses first participants in next cohort Phase I/II UTI/Urosepsis rapid infusion clinical trial

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has dosed the first participants in the next cohort of its Phase I/II UTI/Urosepsis clinical trial with RECCE® 327 (R327).

Read more

Anteris Technologies successfully treats patient with third valve replacement using DurAVR™

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has successfully performed a difficult-to-treat 'valve-in-valve-in-valve' procedure with its DurAVR™ transcatheter aortic valve replacement (TAVR) system — a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue.

Read more

On your six

How the 2024 Federal Budget will impact the investment environment

The Australian Shareholders Association released a statement about the Federal Budget, stating the 2024 Budget should alert shareholders and investors to changes in taxation policies, investment incentives and economic forecasts, which could impact the stock market and individual portfolios.

Read more

The one to watch

Orthocell reports 98.6% success rate in Striate+™ dental membrane study

Orthocell Ltd (ASX:OCC, OTC:ORHHF) CEO and managing director Paul Anderson joins Jonathan Jackson in the Proactive studio to talk through a 98.6% success rate in a post-market clinical study examining the effectiveness of its Striate+™ dental membrane in guided bone regeneration for dental implants.

Watch

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.